Panacea Life Sciences Holdings Inc (PLSH): EXDI is highly undervalued and is just b...

Send PM Follow Ignore

Followers	17
Posts	471
Boards Moderated	0
Alias Born	08/05/2017

SmallCapStockAlert

Re: None

Thursday, 05/23/2019 1:58:35 PM

Thursday, May 23, 2019 1:58:35 PM

EXDI is highly undervalued and is just being discovered. Current growing operations expected to generate $190 million in revenues and $127 million in net income over next 36 months. With very few shares outstanding, projected price is easy $20+.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PLSH News

Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 06/11/2024 09:12:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 05:40:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 01:00:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM